http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2232501-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33b011e77b33662b8bf1f2ff2de7b661 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55594 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55583 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate | 1996-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33a1400e5b09fe6115a999ecebc5ca5d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c1a0e69b1cc2dd78f116aef2fbe8848 |
| publicationDate | 1997-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2232501-A1 |
| titleOfInvention | An immunostimulant and antineoplastic glycan obtained from mycobacterium vaccae |
| abstract | The present invention is a glycan compound with antineoplastic and immunostimulant properties for treating human cancers and as an adjuvant in the formulation of a tuberculosis vaccine, said compound containing at least one component from the class of sugars including arabinose, mannose, glucose and galactose, together with a peptide side chain, having an approximate 60-65 kDa molecular weight, and being readily water-soluble and heat-stable. The invention also is comprised of a process for extracting the glycan compound from the Mycobacterium vaccae, a non-pathogenic, rapid growing member of the mycobacteria. |
| priorityDate | 1995-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 84.